pharma · Amyotrophic Lateral Sclerosis · Acute Myeloid Leukemia
AB Science
AB Science is a pharma organization headquartered in PARIS, FR. Primary therapeutic focus areas include Amyotrophic Lateral Sclerosis, Acute Myeloid Leukemia, Mastocytosis, Mast cell activation syndrome, Multiple Scleros
PARIS, FR HQ
20 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- PARIS, FR
- Employees
- 20
- Programs
- 6
- Drugs
- 11
- Patents
- 25
AB20009
Phase 3 · small molecule · Multiple Sclerosis
AB20009 for Multiple Sclerosis is a Phase 3 program (small_molecule) at AB Science with 1 ClinicalTrials.gov record(s).
Internal code AB20009
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- AB Science
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Multiple Sclerosis
- Status
- active
- Trials
- 1